Epigenomics AG Statistics

Total Valuation

Epigenomics AG has a market cap or net worth of GBP 962,141. The enterprise value is 9.60 million.

Market Cap	962,141
Enterprise Value	9.60M

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+4.72%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	672,136

Valuation Ratios

The trailing PE ratio is 0.38.

PE Ratio	0.38
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	3.82
EV / Sales	83.33
EV / EBITDA	3.59
EV / EBIT	2.73
EV / FCF	n/a

Financial Position

The company has a current ratio of 46.76

Current Ratio	46.76
Quick Ratio	36.58
Debt / Equity	n/a
Debt / EBITDA	3.61
Debt / FCF	n/a
Interest Coverage	92.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	31.99%
Return on Capital (ROIC)	97.35%
Revenue Per Employee	19,249
Profits Per Employee	418,890
Employee Count	6
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-70.79%
50-Day Moving Average	218.43
200-Day Moving Average	284.23
Relative Strength Index (RSI)	21.49
Average Volume (20 Days)	2,713

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Epigenomics AG had revenue of GBP 115,496 and earned 2.51 million in profits. Earnings per share was 2.87.

Revenue	115,496
Gross Profit	103,701
Operating Income	3.53M
Pretax Income	2.51M
Net Income	2.51M
EBITDA	2.68M
EBIT	3.53M
Earnings Per Share (EPS)	2.87

Full Income Statement

Balance Sheet

The company has 1.02 million in cash and 9.68 million in debt, giving a net cash position of -8.66 million.

Cash & Cash Equivalents	1.02M
Total Debt	9.68M
Net Cash	-8.66M
Net Cash Per Share	n/a
Equity (Book Value)	-7.07M
Book Value Per Share	-8.08
Working Capital	1.28M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 89.79%, with operating and profit margins of 3,054.06% and 2,176.13%.

Gross Margin	89.79%
Operating Margin	3,054.06%
Pretax Margin	2,175.39%
Profit Margin	2,176.13%
EBITDA Margin	2,322.57%
EBIT Margin	3,054.06%
FCF Margin	n/a

Dividends & Yields

Epigenomics AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.72%
Shareholder Yield	-4.72%
Earnings Yield	261.22%
FCF Yield	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

Epigenomics AG has an Altman Z-Score of -8.67. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.67
Piotroski F-Score	n/a